ROSEN, NATIONAL TRIAL LAWYERS, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVAPRNewsWire • 09/07/22
SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in ChileBusiness Wire • 09/06/22
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVANewsfile Corp • 09/02/22
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVANewsfile Corp • 08/30/22
SINOVAC BIOTECH LTD. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of MassachusettsPRNewsWire • 08/30/22
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVANewsfile Corp • 08/28/22
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Sinovac Biotech Ltd. (SVA) Investors of Class Action Against 1Globe Capital LLC and to Actively ParticipateBusiness Wire • 08/26/22
ROSEN, A LEADING LAW FIRM, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVANewsfile Corp • 08/25/22
ROSEN, A TOP RANKED FIRM, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVANewsfile Corp • 08/21/22
SINOVAC ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Sinovac Biotech Ltd.Business Wire • 08/19/22
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVAPRNewsWire • 08/19/22
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Blueprint Medicines Corporation with Losses of $100,000 to Contact the FirmBusiness Wire • 08/19/22
EQUITY ALERT: Rosen Law Firm Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers – SVABusiness Wire • 08/17/22
SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong KongBusiness Wire • 08/03/22
SINOVAC Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in ChileBusiness Wire • 07/19/22
SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In BrazilBusiness Wire • 07/14/22
SINOVAC Reports Unaudited Second Half of 2021 Financial Results and Files 2021 Annual Report on Form 20-FBusiness Wire • 04/29/22
Sinovac's COVID-19 Vaccine With Pfizer Booster Less Effective Against Omicron: ReutersBenzinga • 01/03/22
Preliminary Results Show SINOVAC's COVID-19 Vaccine Demonstrates Good Safety Profile Among the Pediatric and Adolescent PopulationBusiness Wire • 11/09/21
